skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hello 5i Team,

A similar question has likely been asked before.

For tax-loss selling purposes in a non-registered account, are QQQ and any other ETF that tracks the NASDAQ 100 index (eg. QQQM) considered different ETFs?

Thanks!
Read Answer Asked by Simon on March 04, 2022
Q: Today, would you buy LNR with p/b of 0.95 and no debt or MG with 2.7B debt and b/b of 1.91. LNR has a wide range of products, other than automotive.
When is LSPD a screaming buy with p/b of 1.13 and 900M in cash?
Many thanks!
Read Answer Asked by Grant on March 04, 2022
Q: I am looking to find some software stocks with excellent Net Revenue Retention rates and strong revenue growth that should make for bounce candidates/long-term compounders if the tech market turns. What are some of your favourite CAD and USD names with NRR above 110% and revenue growth of at least 30%?

Do you like any of SMAR, ASAN or MNDY?

Thanks
Read Answer Asked by Angus on March 04, 2022
Q: Given the increasing implied VOL in options, what are your favourite names in CAD and USD for covered call strategies?

Looking for stocks that you already like that have reasonably liquid options (I know harder in CAD) and you think have excellent bounce back potential and wouldn't mind owning for 2-3 years. Thanks
Read Answer Asked by Angus on March 04, 2022
Q: Good day. I think I made a rookie mistake. A number of months ago I bought 40 shares of Novax, based on emotion and speculation believing its protein spike vaccine would fill the void for vaccine hesitancy and boosters. I am now showing a 56% loss. This stock represents about 3% of my portfolio. Should I sell and take the loss or hang on hoping it turns around upon FDA approval? Thanks for your opinion.
Read Answer Asked by Robert on March 04, 2022
Q: Doc announced today a newly formed public sector division and recent customer contracts across North America that it says will provide “meaningful revenue diversification” and “opportunities to accelerate technology and service integration.”The contracts include agreements to provide integration and technology services to the New York City Department of Education, a substance use disorder solution to support the opioid crisis in North Carolina, and more than 100 new contracts to provide mental health support covering up to 50,000 new employees under subscription services. CloudMD also said it has added several contracts within the public sector division including for a major college employer in Atlantic Canada and mental health coaching for the employees of a major Ontario university. Would appreciate your overview on how significant this announcement is as it seems to tie into Biden's comments in these two areas in his State of the Union Address. The stock was up 20% on the news and traded on high volumes. Thank you
Read Answer Asked by Gordon on March 04, 2022
Q: Good Morning Peter & Team.

I have two questions. Please charge me accordingly. Both have to do with ramifications from increasing cost of OIL.

1. Do you think the ever increasing price of gasoline is going to push more people towards EV and if so, what would be your recommended play to take advantage of this?

2. Commodities especially those coming from mining, and especially those used in the EV industry, appear to be on the rise. What recommendations would you make for us to take advantage of this trend? Right now I have RIO & DML on my radar.

Thanks for all you do

gm
Read Answer Asked by Gord on March 04, 2022
Q: Hello. I bought LSPD in May of 2021 and NVEI in September of 2021. They were both doing great but I'm now down 65% on LSPD and 59% on NVEI. I'm planning on holding them both for the rest of the year and see what happens. I had some significant gains last year so I can use the losses against those if they don't recover, but I'm also open to waiting longer. What would your advice be?
Read Answer Asked by Andrew on March 04, 2022
Q: Dear 5i team.

I see AT is set to report 3/10. In view of this, can you let us know what is expected and what your educated guess would be if they miss/beat? In other words, your opinion on risk reward from these levels would be appreciated.

Many thanks.
Read Answer Asked by Arthur on March 04, 2022
Q: My apologies if this has been asked before, as I'm guessing it has but I just can't find the thread. Regardless, here goes: given the situation in the Ukraine, and the general instability that this brings, I am a bit perplexed with the recent strength in markets. My portfolio is actually up (slightly), as everything seems to have traction. Your thoughts ?
Read Answer Asked by Mike on March 04, 2022